NovMetaPharma is a company that specialized in developing first-in-class drugs with differentiated mechanisms related to metabolic disease. We will lead the global market for treating metabolic diseases through ingenious technology and efficient development systems.
NovMetaPharma is conducting various researches for the treatment of metabolic diseases.
NovMetaPharma focuses on the R&D of new drugs through core domestic and international research teams.
NovMetaPharma is expanding its pipeline of new drugs by continuously conducting R&D.
NovMetaPharma is continuously seeking R&D cooperation for new drug development by establishing the best research infrastructure network in each area.